Photo by nci from unsplash
Cancer drugs approved as FDA breakthrough therapies are not necessarily better than those approved through the traditional pathway: Although breakthrough-designated cancer drugs were approved in less time, a recent study… Click to show full abstract
Cancer drugs approved as FDA breakthrough therapies are not necessarily better than those approved through the traditional pathway: Although breakthrough-designated cancer drugs were approved in less time, a recent study reported, they were not associated with gains in progression-free survival or response rates, nor were they safer or more novel than non-breakthrough-designated drugs.
Keywords:
cancer drugs;
benefit breakthrough;
breakthrough cancer;
little benefit;
cancer
Journal Title: Cancer discovery
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer discovery
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!